Open Access. Powered by Scholars. Published by Universities.®
Pharmacy and Pharmaceutical Sciences Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Acute hyperkalemia (1)
- Acute hyperkalemia managementZS-9 (1)
- Anti-neoplastic agents (1)
- Antibiotic stewardship (1)
- Antibiotics (1)
-
- Anticoagulation management (1)
- Anticoagulation reversal (1)
- Antineoplastic medications (1)
- Beer's list (1)
- Bivaliruidin (1)
- CAP (1)
- COVID (1)
- Centralized distribution model (1)
- Clonidine (1)
- Community Acquired Pneumonia (1)
- Coronavirus disease (1)
- Cost (1)
- Distribution (1)
- Diuretic therapy (1)
- Febrile neutropenia (1)
- Geriatric pharmacology (1)
- HIT (1)
- Hematologic cancer (1)
- Heparin (1)
- Heparin-induced thrombocytopenia (1)
- INR (1)
- Immunologic dose-response relationship (1)
- Infusion center (1)
- Infusion-related reactions (1)
- International normalized ratio (1)
- Publication
Articles 1 - 12 of 12
Full-Text Articles in Pharmacy and Pharmaceutical Sciences
Centracare Launch Of Covid Antiviral Therapy, Jessica Miller, Todd Lemke Pharmd, Dennis Heinen Rph
Centracare Launch Of Covid Antiviral Therapy, Jessica Miller, Todd Lemke Pharmd, Dennis Heinen Rph
Nursing Posters
- Efficiently monitor the limited available stock of oral antiviral COVID therapies during surge states
- Prescribe safely and appropriately
- Dispense to patients close to home.
Assessing Real-World Spot Urine Sodium Values During Continuous Intravenous Infusion Of Loop Diuretics, Rachel Propst, Michael Akers
Assessing Real-World Spot Urine Sodium Values During Continuous Intravenous Infusion Of Loop Diuretics, Rachel Propst, Michael Akers
Pharmacy Posters
- The use of spot urine sodium (UNa)>60 mmol/L as an objective measure to guide diuretic therapy in patients receiving bolus intravenous loop diuretics has been associated with increased weight loss and decreased length of stay.
- There is limited published data evaluating UNa use in patients receiving continuous intravenous loop diuretic infusions.
Retrospective Study Of Warfarin Use In The Centracare Family Health Clinic, Lauren Martens, Jessica Lind
Retrospective Study Of Warfarin Use In The Centracare Family Health Clinic, Lauren Martens, Jessica Lind
Pharmacy Posters
Introduction:
- Warfarin is FDA approved for a variety of indications
- Recommended INR goal ranges can vary depending on indication
- Appropriate warfarin management is necessary for safety and efficacy of the medication
- Since November 2019, warfarin has been managed by the ambulatory pharmacist in the Family Health Clinic
Purpose:
- To further understand the patterns of use of warfarin within the CentraCare Family Health Clinic
- Specifically, determine the prevalence of warfarin indications and corresponding INR goals.
Evaluation Of Heparin-Induced Thrombocytopenia Antibody Laboratory Use And Anticoagulation Prescribing Patterns, Piper Swanson, Jesse Greenlee, Gregory Schaefer, Paul Huiras
Evaluation Of Heparin-Induced Thrombocytopenia Antibody Laboratory Use And Anticoagulation Prescribing Patterns, Piper Swanson, Jesse Greenlee, Gregory Schaefer, Paul Huiras
Pharmacy Posters
Introduction
- Heparin-induced thrombocytopenia (HIT) is a rare adverse reaction
- Calculating a 4T score prior to ordering a heparin-PF4 immunoassay is recommended. For a score < 4, HIT probability is low and an assay is not advised
- If high suspicion of HIT (4T greater than or equal to 4), an assay should be ordered, all heparin products discontinued, and a non-heparin anticoagulant initiated.
Purpose
- Determine if heparin immunoassay ordering was indicted according to retrospective 4T score
- Assess anticoagulation prescribing depending on the result of the assay
- Serve as a pre-group for a planned perverse post-HIT order set implementation analysis
Evaluation Of Antibiotic Use And Duration For Febrile Neutropenia, Kayla Jensen, Patricia Aubert, Joy Ward, Ann Wigton
Evaluation Of Antibiotic Use And Duration For Febrile Neutropenia, Kayla Jensen, Patricia Aubert, Joy Ward, Ann Wigton
Pharmacy Posters
Introduction:
- Febrile neutropenia (FN) affects over 80% of patients with hematologic cancer and 10% to 50% of patients with solid tumors
- National Comprehensive Cancer Network (NCCN) guidelines recommend empiric broad-spectrum monotherapy until the absolute neutrophil count (ANC) is over 500 cells/uL.
- Extended durations with broad-spectrum agents leads to increased risk of antibiotic resistance, toxicity and C. difficile infection.
Purpose
- To evaluate antibiotic prescribing patterns for patients with FN to optimize antibiotic stewardship.
Assessing The Use Of Pre-Treatment Medications In The Management Of Infusion-Related Reactions In An Outpatient Infusion Center, Alyssa Boesche, Alyssa Augst, Bill Kuhlman
Assessing The Use Of Pre-Treatment Medications In The Management Of Infusion-Related Reactions In An Outpatient Infusion Center, Alyssa Boesche, Alyssa Augst, Bill Kuhlman
Pharmacy Posters
Introduction
- Infusion-related reactions (IRRs) are well-known adverse drug reactions of many biological agents and antineoplastic medications
- While typically mild-to-moderate in intensity, IRRs can be severe, with potentially life-threatening consequences requiring urgent interventions
- Appropriate use of pre-treatment medications, such as corticosteroids, antihistamines, intravenous fluids, and antiemetics reduces the incidence and severity of IRRs
Purpose
- Evaluate the use of pre-treatment medications in patients with experienced IRRs at an outpatient infusion center
- Identify opportunities to improve treatment plans and reduce the occurrence of IRRs
Evaluating The Effect Of Sodium Zirconium Cyclosilicate In Acute Hyperkalemia Management, Austin Brandes, Hannah Thompson, Paul Huiras
Evaluating The Effect Of Sodium Zirconium Cyclosilicate In Acute Hyperkalemia Management, Austin Brandes, Hannah Thompson, Paul Huiras
Pharmacy Posters
Introduction
- Sodium zirconium cyclosilicate (ZS-9) can acutely decrease serum potassium (K) levels after one dose and may have favorable side effects compared to sodium polystyrene sulfate (SPS).
- ZS-9 replaced oral SPS in the Hyperkalemia Order Set at St. Cloud Hospital in April 2019
Purpose
- To characterize the acute potassium-lowering effects of one 10-gram dose of sodium zirconium cyclosilicate in conjunction with other potassium-lowering medications
Evaluation Of Antibiotic Prescribing Patterns For Community Acquired Pneumonia, Gregory Schaefer, Ann Wigton
Evaluation Of Antibiotic Prescribing Patterns For Community Acquired Pneumonia, Gregory Schaefer, Ann Wigton
Pharmacy Posters
Purpose: To evaluate duration of antibiotic therapy and prescribing patterns for non-ICU CAP at St Cloud Hospital, a tertiary community hospital.
Evaluation Of The Transition To A Fixed-Dose Prothrombin Complex Concentrate Regimen At A Tertiary Regional Medical Center, John Mullen, Lance Mcnab
Evaluation Of The Transition To A Fixed-Dose Prothrombin Complex Concentrate Regimen At A Tertiary Regional Medical Center, John Mullen, Lance Mcnab
Pharmacy Posters
Objective:
- Evaluate order set use in patients that received PCC for emergent warfarin reversal in the emergency department both before and after implementation of a fixed-dose protocol.
- Evaluate INR response to administration of PCC pre- and post- implementation and the percentage of post-infusion INRs that were less than 2 and 1.5.
- Assess cost of therapy before and after implementation of the fixed-dose protocol.
Evaluation Of Neonatal Abstinence Syndrome Management And Prescribing Patterns, Kaylee Erickson, Anthony Wieland, Kaia Ringwald
Evaluation Of Neonatal Abstinence Syndrome Management And Prescribing Patterns, Kaylee Erickson, Anthony Wieland, Kaia Ringwald
Pharmacy Posters
Purpose:
- Identify medications prescribed to manage NAS due to opioids and /or amphetamines.
- Evaluate average daily medication wean rates.
- Assess length of stay (LOS) and length of treatment (LOT)
Decreasing Unnecessary Pharmacy Cost In The Cath Lab, Scott M. Scepaniak, Kristi Patterson
Decreasing Unnecessary Pharmacy Cost In The Cath Lab, Scott M. Scepaniak, Kristi Patterson
Nursing Posters
AngioMax is a single dose heparin alternative introduced in 2002 that is used in cardiac patients undergoing percutaneous intervention (PCI). Bivalirudin costs $377 per dose; heparin is less than $15 per dose. Noting practice variations, the Cath Lab set out to eliminate unnecessary pharmacy cost for PCI patients by:
- Using current literature to inform clinical care
- Standardizing practice
- Using data to track and guide implementation
Medication Assessment In The Older Adult: Using The Beer's List, Gretchen Zunkel
Medication Assessment In The Older Adult: Using The Beer's List, Gretchen Zunkel
Nursing Posters
- Describe appropriate pharmacologic principles of medication use in older adults
- Review Beer's List Criteria (American Geriatric Society)
- Identify inappropriate and/or overlooked medication for the older adult
- Share with BH Unit staff, patients, families